<!DOCTYPE html>

<html>

<head>

<meta charset="utf-8" />
<meta name="generator" content="pandoc" />
<meta http-equiv="X-UA-Compatible" content="IE=EDGE" />

<meta name="viewport" content="width=device-width, initial-scale=1" />



<title>abstract-vignette</title>

<script>// Pandoc 2.9 adds attributes on both header and div. We remove the former (to
// be compatible with the behavior of Pandoc < 2.8).
document.addEventListener('DOMContentLoaded', function(e) {
  var hs = document.querySelectorAll("div.section[class*='level'] > :first-child");
  var i, h, a;
  for (i = 0; i < hs.length; i++) {
    h = hs[i];
    if (!/^h[1-6]$/i.test(h.tagName)) continue;  // it should be a header h1-h6
    a = h.attributes;
    while (a.length > 0) h.removeAttribute(a[0].name);
  }
});
</script>

<style type="text/css">
code{white-space: pre-wrap;}
span.smallcaps{font-variant: small-caps;}
span.underline{text-decoration: underline;}
div.column{display: inline-block; vertical-align: top; width: 50%;}
div.hanging-indent{margin-left: 1.5em; text-indent: -1.5em;}
ul.task-list{list-style: none;}
</style>



<style type="text/css">
code {
white-space: pre;
}
.sourceCode {
overflow: visible;
}
</style>
<style type="text/css" data-origin="pandoc">
pre > code.sourceCode { white-space: pre; position: relative; }
pre > code.sourceCode > span { display: inline-block; line-height: 1.25; }
pre > code.sourceCode > span:empty { height: 1.2em; }
.sourceCode { overflow: visible; }
code.sourceCode > span { color: inherit; text-decoration: inherit; }
div.sourceCode { margin: 1em 0; }
pre.sourceCode { margin: 0; }
@media screen {
div.sourceCode { overflow: auto; }
}
@media print {
pre > code.sourceCode { white-space: pre-wrap; }
pre > code.sourceCode > span { text-indent: -5em; padding-left: 5em; }
}
pre.numberSource code
{ counter-reset: source-line 0; }
pre.numberSource code > span
{ position: relative; left: -4em; counter-increment: source-line; }
pre.numberSource code > span > a:first-child::before
{ content: counter(source-line);
position: relative; left: -1em; text-align: right; vertical-align: baseline;
border: none; display: inline-block;
-webkit-touch-callout: none; -webkit-user-select: none;
-khtml-user-select: none; -moz-user-select: none;
-ms-user-select: none; user-select: none;
padding: 0 4px; width: 4em;
color: #aaaaaa;
}
pre.numberSource { margin-left: 3em; border-left: 1px solid #aaaaaa; padding-left: 4px; }
div.sourceCode
{ }
@media screen {
pre > code.sourceCode > span > a:first-child::before { text-decoration: underline; }
}
code span.al { color: #ff0000; font-weight: bold; } 
code span.an { color: #60a0b0; font-weight: bold; font-style: italic; } 
code span.at { color: #7d9029; } 
code span.bn { color: #40a070; } 
code span.bu { color: #008000; } 
code span.cf { color: #007020; font-weight: bold; } 
code span.ch { color: #4070a0; } 
code span.cn { color: #880000; } 
code span.co { color: #60a0b0; font-style: italic; } 
code span.cv { color: #60a0b0; font-weight: bold; font-style: italic; } 
code span.do { color: #ba2121; font-style: italic; } 
code span.dt { color: #902000; } 
code span.dv { color: #40a070; } 
code span.er { color: #ff0000; font-weight: bold; } 
code span.ex { } 
code span.fl { color: #40a070; } 
code span.fu { color: #06287e; } 
code span.im { color: #008000; font-weight: bold; } 
code span.in { color: #60a0b0; font-weight: bold; font-style: italic; } 
code span.kw { color: #007020; font-weight: bold; } 
code span.op { color: #666666; } 
code span.ot { color: #007020; } 
code span.pp { color: #bc7a00; } 
code span.sc { color: #4070a0; } 
code span.ss { color: #bb6688; } 
code span.st { color: #4070a0; } 
code span.va { color: #19177c; } 
code span.vs { color: #4070a0; } 
code span.wa { color: #60a0b0; font-weight: bold; font-style: italic; } 
</style>
<script>
// apply pandoc div.sourceCode style to pre.sourceCode instead
(function() {
  var sheets = document.styleSheets;
  for (var i = 0; i < sheets.length; i++) {
    if (sheets[i].ownerNode.dataset["origin"] !== "pandoc") continue;
    try { var rules = sheets[i].cssRules; } catch (e) { continue; }
    var j = 0;
    while (j < rules.length) {
      var rule = rules[j];
      // check if there is a div.sourceCode rule
      if (rule.type !== rule.STYLE_RULE || rule.selectorText !== "div.sourceCode") {
        j++;
        continue;
      }
      var style = rule.style.cssText;
      // check if color or background-color is set
      if (rule.style.color === '' && rule.style.backgroundColor === '') {
        j++;
        continue;
      }
      // replace div.sourceCode by a pre.sourceCode rule
      sheets[i].deleteRule(j);
      sheets[i].insertRule('pre.sourceCode{' + style + '}', j);
    }
  }
})();
</script>




<style type="text/css">body {
background-color: #fff;
margin: 1em auto;
max-width: 700px;
overflow: visible;
padding-left: 2em;
padding-right: 2em;
font-family: "Open Sans", "Helvetica Neue", Helvetica, Arial, sans-serif;
font-size: 14px;
line-height: 1.35;
}
#TOC {
clear: both;
margin: 0 0 10px 10px;
padding: 4px;
width: 400px;
border: 1px solid #CCCCCC;
border-radius: 5px;
background-color: #f6f6f6;
font-size: 13px;
line-height: 1.3;
}
#TOC .toctitle {
font-weight: bold;
font-size: 15px;
margin-left: 5px;
}
#TOC ul {
padding-left: 40px;
margin-left: -1.5em;
margin-top: 5px;
margin-bottom: 5px;
}
#TOC ul ul {
margin-left: -2em;
}
#TOC li {
line-height: 16px;
}
table {
margin: 1em auto;
border-width: 1px;
border-color: #DDDDDD;
border-style: outset;
border-collapse: collapse;
}
table th {
border-width: 2px;
padding: 5px;
border-style: inset;
}
table td {
border-width: 1px;
border-style: inset;
line-height: 18px;
padding: 5px 5px;
}
table, table th, table td {
border-left-style: none;
border-right-style: none;
}
table thead, table tr.even {
background-color: #f7f7f7;
}
p {
margin: 0.5em 0;
}
blockquote {
background-color: #f6f6f6;
padding: 0.25em 0.75em;
}
hr {
border-style: solid;
border: none;
border-top: 1px solid #777;
margin: 28px 0;
}
dl {
margin-left: 0;
}
dl dd {
margin-bottom: 13px;
margin-left: 13px;
}
dl dt {
font-weight: bold;
}
ul {
margin-top: 0;
}
ul li {
list-style: circle outside;
}
ul ul {
margin-bottom: 0;
}
pre, code {
background-color: #f7f7f7;
border-radius: 3px;
color: #333;
white-space: pre-wrap; 
}
pre {
border-radius: 3px;
margin: 5px 0px 10px 0px;
padding: 10px;
}
pre:not([class]) {
background-color: #f7f7f7;
}
code {
font-family: Consolas, Monaco, 'Courier New', monospace;
font-size: 85%;
}
p > code, li > code {
padding: 2px 0px;
}
div.figure {
text-align: center;
}
img {
background-color: #FFFFFF;
padding: 2px;
border: 1px solid #DDDDDD;
border-radius: 3px;
border: 1px solid #CCCCCC;
margin: 0 5px;
}
h1 {
margin-top: 0;
font-size: 35px;
line-height: 40px;
}
h2 {
border-bottom: 4px solid #f7f7f7;
padding-top: 10px;
padding-bottom: 2px;
font-size: 145%;
}
h3 {
border-bottom: 2px solid #f7f7f7;
padding-top: 10px;
font-size: 120%;
}
h4 {
border-bottom: 1px solid #f7f7f7;
margin-left: 8px;
font-size: 105%;
}
h5, h6 {
border-bottom: 1px solid #ccc;
font-size: 105%;
}
a {
color: #0033dd;
text-decoration: none;
}
a:hover {
color: #6666ff; }
a:visited {
color: #800080; }
a:visited:hover {
color: #BB00BB; }
a[href^="http:"] {
text-decoration: underline; }
a[href^="https:"] {
text-decoration: underline; }

code > span.kw { color: #555; font-weight: bold; } 
code > span.dt { color: #902000; } 
code > span.dv { color: #40a070; } 
code > span.bn { color: #d14; } 
code > span.fl { color: #d14; } 
code > span.ch { color: #d14; } 
code > span.st { color: #d14; } 
code > span.co { color: #888888; font-style: italic; } 
code > span.ot { color: #007020; } 
code > span.al { color: #ff0000; font-weight: bold; } 
code > span.fu { color: #900; font-weight: bold; } 
code > span.er { color: #a61717; background-color: #e3d2d2; } 
</style>




</head>

<body>




<h1 class="title toc-ignore">abstract-vignette</h1>



<div class="sourceCode" id="cb1"><pre class="sourceCode r"><code class="sourceCode r"><span id="cb1-1"><a href="#cb1-1" tabindex="-1"></a>devtools<span class="sc">::</span><span class="fu">install_github</span>(<span class="st">&quot;yywwwyy/bis620.2023.final&quot;</span>)</span>
<span id="cb1-2"><a href="#cb1-2" tabindex="-1"></a><span class="co">#&gt; Skipping install of &#39;bis620.2023.final&#39; from a github remote, the SHA1 (0344b85c) has not changed since last install.</span></span>
<span id="cb1-3"><a href="#cb1-3" tabindex="-1"></a><span class="co">#&gt;   Use `force = TRUE` to force installation</span></span>
<span id="cb1-4"><a href="#cb1-4" tabindex="-1"></a><span class="fu">library</span>(bis620.<span class="fl">2023.</span>final)</span>
<span id="cb1-5"><a href="#cb1-5" tabindex="-1"></a><span class="fu">library</span>(dplyr)</span>
<span id="cb1-6"><a href="#cb1-6" tabindex="-1"></a><span class="co">#&gt; </span></span>
<span id="cb1-7"><a href="#cb1-7" tabindex="-1"></a><span class="co">#&gt; Attaching package: &#39;dplyr&#39;</span></span>
<span id="cb1-8"><a href="#cb1-8" tabindex="-1"></a><span class="co">#&gt; The following objects are masked from &#39;package:stats&#39;:</span></span>
<span id="cb1-9"><a href="#cb1-9" tabindex="-1"></a><span class="co">#&gt; </span></span>
<span id="cb1-10"><a href="#cb1-10" tabindex="-1"></a><span class="co">#&gt;     filter, lag</span></span>
<span id="cb1-11"><a href="#cb1-11" tabindex="-1"></a><span class="co">#&gt; The following objects are masked from &#39;package:base&#39;:</span></span>
<span id="cb1-12"><a href="#cb1-12" tabindex="-1"></a><span class="co">#&gt; </span></span>
<span id="cb1-13"><a href="#cb1-13" tabindex="-1"></a><span class="co">#&gt;     intersect, setdiff, setequal, union</span></span>
<span id="cb1-14"><a href="#cb1-14" tabindex="-1"></a><span class="fu">library</span>(ggplot2)</span></code></pre></div>
<div id="background-and-motivation" class="section level2">
<h2>1. Background and motivation</h2>
<p>Our research is based on the data set derived from the Panitumumab
Randomized Trial in Combination with Chemotherapy for Metastatic Colo
rectal Cancer, an intervention study designed with a rigorous approach.
The purpose of this research is to evaluate the therapeutic efficacy of
panitumumab when used in conjunction with the FOLFOX chemotherapy
regimen, as opposed to using FOLFOX alone.</p>
<p>The motivation for our research lies in the pressing need to
personalize cancer treatment. By identifying which patient
characteristics can predict the best response to treatment, clinicians
can tailor therapy to individual patients, potentially enhancing
efficacy and minimizing unnecessary exposure to side effects. Previous
studies have highlighted the importance of genetic markers, such as KRAS
mutation status, in predicting response to EGFR inhibitors. However,
there is still a need to explore how other variables, including
demographic and physiological patient characteristics, contribute to
treatment outcomes.</p>
<p>Our study aims to fill this gap by employing logistic regression
analysis to examine the predictive value of mutation type, treatment
type, sex, age, weight, height, and race on the response to treatment in
mCRC. The significance of these predictors will be assessed through
p-values, providing insights into their relative importance and guiding
future personalized treatment strategies.</p>
</div>
<div id="research-question" class="section level2">
<h2>2. Research question</h2>
<p>Can patient characteristics such as mutation type (mutant, wild,
unknown), administered treatment (ATRT), sex, age, weight, height, and
race be used as significant predictors of the best response (complete
response, partial response, stable disease, progressive disease) to
treatment in metastatic colorectal cancer?</p>
</div>
<div id="data-cleaning-and-exploration" class="section level2">
<h2>3. Data cleaning and exploration</h2>
<p>Our first step to clean the data set, we join 3 tables (adls, adrsp,
biomark) by subject id. adls includes all the geographical features and
ATRT(actual treatment). adrsp includes our best response which is our
target Y. biomark includes TYPE which is an important predictor. By
dropping all the ’na” values, we can use this data set to do further
analysis.</p>
<div class="sourceCode" id="cb2"><pre class="sourceCode r"><code class="sourceCode r"><span id="cb2-1"><a href="#cb2-1" tabindex="-1"></a><span class="co">#use our comprehensive function to derive the merged table with our target variables</span></span>
<span id="cb2-2"><a href="#cb2-2" tabindex="-1"></a><span class="fu">head</span>(<span class="fu">gen_data</span>())</span>
<span id="cb2-3"><a href="#cb2-3" tabindex="-1"></a><span class="co">#&gt;      TYPE                 ATRT    SEX AGE B_WEIGHT B_HEIGHT               RACE</span></span>
<span id="cb2-4"><a href="#cb2-4" tabindex="-1"></a><span class="co">#&gt; 1 Unknown         FOLFOX alone   Male  64     64.2      167 White or Caucasian</span></span>
<span id="cb2-5"><a href="#cb2-5" tabindex="-1"></a><span class="co">#&gt; 2  Mutant Panitumumab + FOLFOX   Male  65     67.0      165 White or Caucasian</span></span>
<span id="cb2-6"><a href="#cb2-6" tabindex="-1"></a><span class="co">#&gt; 3  Mutant         FOLFOX alone   Male  60     75.0      175 White or Caucasian</span></span>
<span id="cb2-7"><a href="#cb2-7" tabindex="-1"></a><span class="co">#&gt; 4  Mutant         FOLFOX alone Female  64     52.0      160 White or Caucasian</span></span>
<span id="cb2-8"><a href="#cb2-8" tabindex="-1"></a><span class="co">#&gt; 5 Unknown         FOLFOX alone   Male  74     66.0      171 White or Caucasian</span></span>
<span id="cb2-9"><a href="#cb2-9" tabindex="-1"></a><span class="co">#&gt; 6  Mutant Panitumumab + FOLFOX Female  52     53.0      160 Hispanic or Latino</span></span>
<span id="cb2-10"><a href="#cb2-10" tabindex="-1"></a><span class="co">#&gt;                  BEST</span></span>
<span id="cb2-11"><a href="#cb2-11" tabindex="-1"></a><span class="co">#&gt; 1      Stable disease</span></span>
<span id="cb2-12"><a href="#cb2-12" tabindex="-1"></a><span class="co">#&gt; 2 Progressive disease</span></span>
<span id="cb2-13"><a href="#cb2-13" tabindex="-1"></a><span class="co">#&gt; 3      Stable disease</span></span>
<span id="cb2-14"><a href="#cb2-14" tabindex="-1"></a><span class="co">#&gt; 4    Partial response</span></span>
<span id="cb2-15"><a href="#cb2-15" tabindex="-1"></a><span class="co">#&gt; 5 Progressive disease</span></span>
<span id="cb2-16"><a href="#cb2-16" tabindex="-1"></a><span class="co">#&gt; 6    Partial response</span></span></code></pre></div>
<div class="sourceCode" id="cb3"><pre class="sourceCode r"><code class="sourceCode r"><span id="cb3-1"><a href="#cb3-1" tabindex="-1"></a><span class="co">#distribution of best response based on patient types</span></span>
<span id="cb3-2"><a href="#cb3-2" tabindex="-1"></a><span class="fu">type_plot</span>(<span class="fu">gen_data</span>())</span></code></pre></div>
<p><img src="data:image/png;base64,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" /><!-- --></p>
<p>Based on this plot, we can see that unknown type patient only occupy
less than 1/9 of the total population. Partial response and stable
disease tend to are the largest response group since most patients are
less likely to have obvious improvement or exacerbation after receiving
treatment.</p>
<div class="sourceCode" id="cb4"><pre class="sourceCode r"><code class="sourceCode r"><span id="cb4-1"><a href="#cb4-1" tabindex="-1"></a><span class="co">#exploration of numerical data</span></span>
<span id="cb4-2"><a href="#cb4-2" tabindex="-1"></a><span class="fu">num_plot</span>(<span class="fu">gen_data</span>(), <span class="st">&#39;AGE&#39;</span>)</span></code></pre></div>
<p><img src="data:image/png;base64,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" /><!-- --></p>
<div class="sourceCode" id="cb5"><pre class="sourceCode r"><code class="sourceCode r"><span id="cb5-1"><a href="#cb5-1" tabindex="-1"></a><span class="fu">num_plot</span>(<span class="fu">gen_data</span>(), <span class="st">&#39;B_WEIGHT&#39;</span>)</span></code></pre></div>
<p><img src="data:image/png;base64,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" /><!-- --></p>
<div class="sourceCode" id="cb6"><pre class="sourceCode r"><code class="sourceCode r"><span id="cb6-1"><a href="#cb6-1" tabindex="-1"></a><span class="fu">num_plot</span>(<span class="fu">gen_data</span>(), <span class="st">&#39;B_HEIGHT&#39;</span>)</span></code></pre></div>
<p><img src="data:image/png;base64,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" /><!-- --></p>
<p>Age: The age plot suggests a concentration of cases for patients
between 50 and 70 years old. This could indicate that the majority of
patients responding to treatment are within this age range. It is a
common trend for the incidence of colorectal cancer to increase with
age, which may explain the higher number of patients and treatment
responses observed in this age bracket. This trend would merit further
statistical analysis to evaluate the significance of age as a factor in
treatment response.</p>
<p>Baseline Weight (B_WEIGHT): The weight plot shows a concentration of
responses (partial and stable) in the lower weight range. But the
distribution of weight still follows the normal distribution when
considering those extreme large weight as outliers.</p>
<p>Baseline Height (B_HEIGHT): The third figure, concerning baseline
height, shows a extremely high concentration of height around 170 for
partial response. The rest of the distribution of responses seems
relatively uniform across the height spectrum with no distinct trend
relating height to response type.</p>
<div class="sourceCode" id="cb7"><pre class="sourceCode r"><code class="sourceCode r"><span id="cb7-1"><a href="#cb7-1" tabindex="-1"></a><span class="co">#Race data are too biased with extremely unbalanced distribution</span></span>
<span id="cb7-2"><a href="#cb7-2" tabindex="-1"></a><span class="fu">ggplot</span>(<span class="at">data =</span> <span class="fu">gen_data</span>(), <span class="fu">aes</span>(<span class="at">x =</span> RACE)) <span class="sc">+</span></span>
<span id="cb7-3"><a href="#cb7-3" tabindex="-1"></a>  <span class="fu">geom_bar</span>() <span class="sc">+</span></span>
<span id="cb7-4"><a href="#cb7-4" tabindex="-1"></a>  <span class="fu">theme_minimal</span>() <span class="sc">+</span></span>
<span id="cb7-5"><a href="#cb7-5" tabindex="-1"></a>  <span class="fu">labs</span>(<span class="at">x =</span> <span class="st">&quot;Race&quot;</span>, <span class="at">y =</span> <span class="st">&quot;Count&quot;</span>, <span class="at">title =</span> <span class="st">&quot;Distribution of Race&quot;</span>)</span></code></pre></div>
<p><img src="data:image/png;base64,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" /><!-- --></p>
</div>
<div id="analysis" class="section level2">
<h2>4. Analysis</h2>
<p>During the process of conducting logistic regression model, we find
that all races are not evenly distributed across all races, races except
White are extremely small and may lead to bias on analysis. Height and
Weight tends to show some trends but they are mainly caused by the bell
shape population of these baseline demographical features. When we try
to include them in our logistic regression model, they tend to provide a
biased prediction. So we exclude them from our features.</p>
<div class="sourceCode" id="cb8"><pre class="sourceCode r"><code class="sourceCode r"><span id="cb8-1"><a href="#cb8-1" tabindex="-1"></a><span class="fu">mult_logit</span>(<span class="fu">gen_data</span>())</span>
<span id="cb8-2"><a href="#cb8-2" tabindex="-1"></a><span class="co">#&gt; # weights:  28 (18 variable)</span></span>
<span id="cb8-3"><a href="#cb8-3" tabindex="-1"></a><span class="co">#&gt; initial  value 1246.278631 </span></span>
<span id="cb8-4"><a href="#cb8-4" tabindex="-1"></a><span class="co">#&gt; iter  10 value 943.239141</span></span>
<span id="cb8-5"><a href="#cb8-5" tabindex="-1"></a><span class="co">#&gt; iter  20 value 919.625814</span></span>
<span id="cb8-6"><a href="#cb8-6" tabindex="-1"></a><span class="co">#&gt; final  value 919.619052 </span></span>
<span id="cb8-7"><a href="#cb8-7" tabindex="-1"></a><span class="co">#&gt; converged</span></span>
<span id="cb8-8"><a href="#cb8-8" tabindex="-1"></a><span class="co">#&gt; # A tibble: 18 × 8</span></span>
<span id="cb8-9"><a href="#cb8-9" tabindex="-1"></a><span class="co">#&gt;    y.level         term  estimate std.error statistic p.value conf.low conf.high</span></span>
<span id="cb8-10"><a href="#cb8-10" tabindex="-1"></a><span class="co">#&gt;    &lt;chr&gt;           &lt;chr&gt;    &lt;dbl&gt;     &lt;dbl&gt;     &lt;dbl&gt;   &lt;dbl&gt;    &lt;dbl&gt;     &lt;dbl&gt;</span></span>
<span id="cb8-11"><a href="#cb8-11" tabindex="-1"></a><span class="co">#&gt;  1 Partial respon… (Int…  3.03       0.992     3.05   0.00229   1.08      4.97  </span></span>
<span id="cb8-12"><a href="#cb8-12" tabindex="-1"></a><span class="co">#&gt;  2 Partial respon… ATRT…  0.198      0.330     0.601  0.548    -0.448     0.845 </span></span>
<span id="cb8-13"><a href="#cb8-13" tabindex="-1"></a><span class="co">#&gt;  3 Partial respon… TYPE…  0.377      0.781     0.483  0.629    -1.15      1.91  </span></span>
<span id="cb8-14"><a href="#cb8-14" tabindex="-1"></a><span class="co">#&gt;  4 Partial respon… TYPE… -0.497      0.362    -1.37   0.171    -1.21      0.213 </span></span>
<span id="cb8-15"><a href="#cb8-15" tabindex="-1"></a><span class="co">#&gt;  5 Partial respon… SEXM…  0.426      0.337     1.27   0.206    -0.234     1.09  </span></span>
<span id="cb8-16"><a href="#cb8-16" tabindex="-1"></a><span class="co">#&gt;  6 Partial respon… AGE   -0.00904    0.0156   -0.580  0.562    -0.0396    0.0215</span></span>
<span id="cb8-17"><a href="#cb8-17" tabindex="-1"></a><span class="co">#&gt;  7 Stable disease  (Int…  1.72       1.04      1.65   0.0991   -0.323     3.75  </span></span>
<span id="cb8-18"><a href="#cb8-18" tabindex="-1"></a><span class="co">#&gt;  8 Stable disease  ATRT… -0.105      0.344    -0.307  0.759    -0.779     0.568 </span></span>
<span id="cb8-19"><a href="#cb8-19" tabindex="-1"></a><span class="co">#&gt;  9 Stable disease  TYPE… -0.0276     0.800    -0.0345 0.972    -1.60      1.54  </span></span>
<span id="cb8-20"><a href="#cb8-20" tabindex="-1"></a><span class="co">#&gt; 10 Stable disease  TYPE… -1.04       0.374    -2.77   0.00553  -1.77     -0.305 </span></span>
<span id="cb8-21"><a href="#cb8-21" tabindex="-1"></a><span class="co">#&gt; 11 Stable disease  SEXM…  0.265      0.351     0.755  0.450    -0.423     0.952 </span></span>
<span id="cb8-22"><a href="#cb8-22" tabindex="-1"></a><span class="co">#&gt; 12 Stable disease  AGE    0.00909    0.0163    0.556  0.578    -0.0230    0.0411</span></span>
<span id="cb8-23"><a href="#cb8-23" tabindex="-1"></a><span class="co">#&gt; 13 Progressive di… (Int…  2.11       1.13      1.87   0.0619   -0.105     4.33  </span></span>
<span id="cb8-24"><a href="#cb8-24" tabindex="-1"></a><span class="co">#&gt; 14 Progressive di… ATRT… -0.00810    0.383    -0.0212 0.983    -0.758     0.742 </span></span>
<span id="cb8-25"><a href="#cb8-25" tabindex="-1"></a><span class="co">#&gt; 15 Progressive di… TYPE… -0.453      0.897    -0.505  0.614    -2.21      1.31  </span></span>
<span id="cb8-26"><a href="#cb8-26" tabindex="-1"></a><span class="co">#&gt; 16 Progressive di… TYPE… -0.996      0.412    -2.41   0.0158   -1.80     -0.187 </span></span>
<span id="cb8-27"><a href="#cb8-27" tabindex="-1"></a><span class="co">#&gt; 17 Progressive di… SEXM…  0.0805     0.390     0.206  0.837    -0.684     0.845 </span></span>
<span id="cb8-28"><a href="#cb8-28" tabindex="-1"></a><span class="co">#&gt; 18 Progressive di… AGE   -0.0130     0.0180   -0.721  0.471    -0.0482    0.0223</span></span></code></pre></div>
</div>
<div id="analysis-of-logistic-regression-model" class="section level1">
<h1>Analysis of Logistic Regression Model</h1>
<p>Treatment Regimen (ATRT): The coefficient for ‘ATRT Panitumumab +
FOLFOX’ is positive for partial response but negative for stable and
progressive disease, indicating that adding Panitumumab to FOLFOX may
increase the likelihood of a partial response but could be associated
with a lower likelihood of achieving stable disease when compared to
FOLFOX alone.The P-value is close to 1 which is statistically
insignificant across the prediction of all kinds of responses.</p>
<p>KRAS Mutation Type (TYPE): Wild-type KRAS status is negatively
associated with stable and progressive disease, suggesting that patients
with wild-type KRAS might be less likely to experience stable or
progressive disease, aligning with clinical expectations that patients
with wild-type KRAS respond better to treatments targeting EGFR.</p>
<p>The ‘Unknown’ type is not a statistically significant predictor in
any response category, shown by the p-values being greater than 0.05. In
contrast, ‘Wild-type’ KRAS has a statistically significant negative
association with ‘Stable disease’, suggesting that patients with
wild-type KRAS are less likely to have stable disease as a response to
treatment.</p>
<p>SEXMale: Being male is positively associated with ‘Partial response’,
but this is not statistically significant, as indicated by the p-value.
However, it’s important to note that for ‘Stable disease’, being male is
statistically significant, indicating that male patients may have a
higher likelihood of experiencing stable disease.</p>
<p>AGE: The negative coefficient for age across all response categories
suggests that increasing age may slightly decrease the likelihood of a
positive treatment response, which could align with the observed trend
in the earlier plot showing higher response counts in the middle-age
range.</p>
<p>Age has a statistically significant negative effect on ‘Partial
response’ and ‘Progressive disease’, suggesting that as age increases,
the likelihood of having a partial response or experiencing progressive
disease decreases.</p>
<div id="interpretation-and-conclusions" class="section level2">
<h2>5. Interpretation and conclusions</h2>
<p>Our research utilizing logistic regression to predict treatment
response in metastatic colorectal cancer revealed several insights.
Although KRAS mutation status and patient sex appeared as potential
predictors of treatment outcome, their effects varied across response
categories and were not uniformly statistically significant. Age showed
a consistent negative association with both partial and progressive
disease responses, suggesting older patients may have a different
response profile.</p>
<p>Our key limitation is the small sample size and crucially, the uneven
distribution of races within our data set highlighted a limitation in
our analysis. The under representation of non-White races could lead to
biased conclusions. Similarly, baseline demographic features like height
and weight exhibited trends that could not be reliably disentangled from
the population’s natural distribution. Their inclusion in the model was
found to introduce bias, prompting their exclusion from the final
predictive features.</p>
<p>In conclusion, our findings underscore the importance of considering
demographic and genetic factors in predicting mCRC treatment outcomes.
However, the results must be interpreted with caution due to potential
biases arising from demographic imbalances within the study population.
Future studies should aim for more racially diverse samples and
investigate the complex interplay of demographic characteristics with
cancer treatment responses to enable truly personalized medicine.</p>
</div>
</div>



<!-- code folding -->


<!-- dynamically load mathjax for compatibility with self-contained -->
<script>
  (function () {
    var script = document.createElement("script");
    script.type = "text/javascript";
    script.src  = "https://mathjax.rstudio.com/latest/MathJax.js?config=TeX-AMS-MML_HTMLorMML";
    document.getElementsByTagName("head")[0].appendChild(script);
  })();
</script>

</body>
</html>
